Compare HURN & LMAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HURN | LMAT |
|---|---|---|
| Founded | 2002 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Professional Services | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 2.6B |
| IPO Year | 2004 | 2006 |
| Metric | HURN | LMAT |
|---|---|---|
| Price | $116.22 | $102.17 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 5 |
| Target Price | ★ $204.40 | $105.80 |
| AVG Volume (30 Days) | ★ 204.4K | 166.4K |
| Earning Date | 05-05-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 0.93% |
| EPS Growth | N/A | ★ 30.57 |
| EPS | ★ 1.34 | 0.68 |
| Revenue | ★ $1,699,143,000.00 | $249,602,000.00 |
| Revenue This Year | $11.80 | $14.21 |
| Revenue Next Year | $8.23 | $8.88 |
| P/E Ratio | ★ $89.72 | $159.13 |
| Revenue Growth | 11.65 | ★ 13.53 |
| 52 Week Low | $112.45 | $78.35 |
| 52 Week High | $186.78 | $118.01 |
| Indicator | HURN | LMAT |
|---|---|---|
| Relative Strength Index (RSI) | 36.27 | 34.57 |
| Support Level | N/A | $82.24 |
| Resistance Level | $136.05 | $114.83 |
| Average True Range (ATR) | 5.96 | 4.82 |
| MACD | -0.95 | -1.16 |
| Stochastic Oscillator | 18.42 | 3.84 |
Huron Consulting Group Inc is a professional services firm. The company provides expertise in technology, operations, advisory services, & analytics through three operating segments namely Healthcare, Education, and Commercial. Healthcare segment helps the firms to transform and innovate the delivery model to focus on patient wellness by improving quality outcomes, minimizing care variation and fundamentally improving patient and population health, Education segment provides management consulting and technology solutions, and Commercial segment is focused on serving industries and organizations facing disruption and regulatory change. It generates a majority of its revenue from the Healthcare Segment.
LeMaitre Vascular Inc is a provider of medical devices and human tissue cryopreservation services mainly used in the treatment of peripheral vascular disease, end-stage renal disease, and cardiovascular disease. The company develops, manufactures, and markets vascular devices to address the needs of vascular surgeons and, to a lesser extent, other specialties such as cardiac surgeons, general surgeons, and neurosurgeons. Its diversified portfolio consists of branded products used in arteries and veins that are well known to vascular surgeons. It operates across the Americas, Europe, the Middle East and Africa, and Asia Pacific, with the majority of its revenue generated from the Americas.